Patents by Inventor James E. Smous

James E. Smous has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9554735
    Abstract: A system for determining the concentration of an analyte in at least one body fluid in body tissue comprises an infrared light source, a body tissue interface, a detector, and a central processing unit. The body tissue interface is adapted to contact body tissue and to deliver light from the infrared light source to the contacted body tissue. The detector is adapted to receive spectral information corresponding to infrared light transmitted through the portion of body tissue being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid, the algorithm adapted to convert the received spectral information into the concentration of the analyte in at least one body fluid.
    Type: Grant
    Filed: April 26, 2013
    Date of Patent: January 31, 2017
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Mihailo V. Rebec, James E. Smous, Steven D. Brown, Hu-Wei Tan
  • Publication number: 20130261406
    Abstract: A system for determining the concentration of an analyte in at least one body fluid in body tissue comprises an infrared light source, a body tissue interface, a detector, and a central processing unit. The body tissue interface is adapted to contact body tissue and to deliver light from the infrared light source to the contacted body tissue. The detector is adapted to receive spectral information corresponding to infrared light transmitted through the portion of body tissue being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid, the algorithm adapted to convert the received spectral information into the concentration of the analyte in at least one body fluid.
    Type: Application
    Filed: April 26, 2013
    Publication date: October 3, 2013
    Applicant: Bayer HealthCare LLC
    Inventors: Mihailo V. Rebec, James E. Smous, Steven D. Brown, Hu-Wei Tan
  • Patent number: 8452359
    Abstract: A system for determining the concentration of an analyte in at least one body fluid in body tissue comprises an infrared light source, a body tissue interface, a detector, and a central processing unit. The body tissue interface is adapted to contact body tissue and to deliver light from the infrared light source to the contacted body tissue. The detector is adapted to receive spectral information corresponding to infrared light transmitted through the portion of body tissue being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid, the algorithm adapted to convert the received spectral information into the concentration of the analyte in at least one body fluid.
    Type: Grant
    Filed: October 10, 2007
    Date of Patent: May 28, 2013
    Assignee: Bayer HealthCare LLC
    Inventors: Mihailo V. Rebec, James E. Smous, Steven D. Brown, Hu-Wei Tan
  • Patent number: 8160666
    Abstract: A system for determining the concentration of an analyte in at least one body fluid in body tissue comprises an infrared light source, a body tissue interface, a detector, and a central processing unit. The body tissue interface is adapted to contact body tissue and to deliver light from the infrared light source to the contacted body tissue. The detector is adapted to receive spectral information corresponding to infrared light transmitted through the portion of body tissue being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid, the algorithm adapted to convert the received spectral information into the concentration of the analyte in at least one body fluid.
    Type: Grant
    Filed: October 12, 2007
    Date of Patent: April 17, 2012
    Assignee: Bayer Healthcare LLC
    Inventors: Mihailo V. Rebec, James E. Smous, Steven D. Brown, Hu-Wei Tan
  • Patent number: 7944556
    Abstract: A spectral image is corrected for optical aberrations. Tissue is exposed to a high-intensity, narrow band of light. The narrow band of light is scattered by at least one analyte in the tissue. Raman signals are optically collected from the scattered light. The Raman signals are directed to a wavelength-separating device. The Raman signals are detected as a function of intensity and wavelength to create the spectral image. The spectral image is corrected for optical aberrations using a software algorithm to spatially reassign intensity. The software may be adapted to use a reference image to make dynamic corrections. Fluorescence signals may also be collected.
    Type: Grant
    Filed: March 11, 2010
    Date of Patent: May 17, 2011
    Assignee: Bayer HealthCare LLC
    Inventors: James E. Smous, Mihailo V. Rebec, Michael P. Houlne
  • Patent number: 7896819
    Abstract: A method of obtaining a body fluid sample for determining the concentration of an analyte in the body fluid sample comprises applying pressure to the skin of the user. The skin is stretched so as to create a tear in the skin such that the applied pressure causes the body fluid to flow from the tear. The body fluid flowing from the tear is collected. Disclosed is also a pressure member for applying pressure to and stretching skin in preparation for forming a tear in the skin.
    Type: Grant
    Filed: October 20, 2005
    Date of Patent: March 1, 2011
    Inventors: Mihailo V. Rebec, James E. Smous, Bryan S. Melle, Pamela J. Burson
  • Publication number: 20100226549
    Abstract: A spectral image is corrected for optical aberrations. Tissue is exposed to a high-intensity, narrow band of light. The narrow band of light is scattered by at least one analyte in the tissue. Raman signals are optically collected from the scattered light. The Raman signals are directed to a wavelength-separating device. The Raman signals are detected as a function of intensity and wavelength to create the spectral image. The spectral image is corrected for optical aberrations using a software algorithm to spatially reassign intensity. The software may be adapted to use a reference image to make dynamic corrections. Fluorescence signals may also be collected.
    Type: Application
    Filed: March 11, 2010
    Publication date: September 9, 2010
    Applicant: Bayer HealthCare, LLC
    Inventors: JAMES E. SMOUS, Mihailo V. Rebec, Michael P. Houlne
  • Publication number: 20100113897
    Abstract: A continuous analyte monitoring assembly is adapted to assist in determining an analyte level of a fluid. The monitoring assembly includes a housing, electronics, an implantable sensor and a cannula. The housing has a bottom in which the bottom forms a recess. The electronics are located within the housing and assist in determining an analyte level of a fluid sample. The sensor moves from a retracted position to an inserted position using the recess. The cannula assists in placing the implantable sensor.
    Type: Application
    Filed: March 14, 2008
    Publication date: May 6, 2010
    Applicant: Bayer Health Care LLC
    Inventors: Allen J. Brenneman, James E. Smous
  • Patent number: 7705980
    Abstract: A spectral image is corrected for optical aberrations. Tissue is exposed to a high-intensity, narrow band of light. The narrow band of light is scattered by at least one analyte in the tissue. Raman signals are optically collected from the scattered light. The Raman signals are directed to a wavelength-separating device. The Raman signals are detected as a function of intensity and wavelength to create the spectral image. The spectral image is corrected for optical aberrations using a software algorithm to spatially reassign intensity. The software may be adapted to use a reference image to make dynamic corrections. Fluorescence signals may also be collected.
    Type: Grant
    Filed: August 21, 2007
    Date of Patent: April 27, 2010
    Assignee: Bayer Healthcare LLC
    Inventors: James E. Smous, Mihailo V. Rebec, Michael P. Houlne
  • Publication number: 20080092638
    Abstract: A system for monitoring a concentration of an analyte in a fluid or tissue sample. The system comprises a sensor module adapted to be borne on a patient. The sensor module includes a power supply adapted to provide a transmission power, a first transceiver adapted to transmit analyte-concentration information, and a memory. The system further comprises a remote monitoring device adapted to wirelessly communicate with the sensor module. The remote monitoring device includes a second transceiver adapted to receive the analyte-concentration information transmitted by the sensor module and adapted to transmit a signal to the sensor module confirming that the analyte-concentration information was received. The information is stored in the memory until the signal is received by the sensor module.
    Type: Application
    Filed: October 2, 2007
    Publication date: April 24, 2008
    Inventors: Allen J. Brenneman, Mihailo V. Rebec, James E. Smous
  • Patent number: 7299079
    Abstract: A system for determining the concentration of an analyte in at least one body fluid in body tissue, the system comprising an infrared light source, a body tissue interface, a detector, and a central processing unit. The body tissue interface is adapted to contact body tissue and to deliver light from the infrared light source to the contacted body tissue. The detector is adapted to receive spectral information corresponding to infrared light transmitted through the portion of body tissue being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid, the algorithm adapted to convert the received spectral information into the concentration of the analyte in at least one body fluid.
    Type: Grant
    Filed: February 11, 2003
    Date of Patent: November 20, 2007
    Assignee: Bayer HealthCare LLC
    Inventors: Mihailo V. Rebec, James E. Smous, Steven D. Brown, Hu-Wei Tan
  • Patent number: 7285425
    Abstract: A device for evaluating at least one analyte in a test sample. The device comprises a cassette having a hollow test chamber, a test strip disposed within the test chamber for receiving the test sample, and a temperature control member. The cassette has at least one aperture extending from an exterior of the cassette to the hollow test chamber. The test strip includes a reagent adapted to react with the at least one analyte to produce a reaction indicative of the presence of the analyte. The temperature control member is adapted to extend through the at least one aperture in the cassette and into the test chamber for controlling the temperature of the test chamber.
    Type: Grant
    Filed: May 14, 2002
    Date of Patent: October 23, 2007
    Assignee: Siemens Medical Solutions Diagnostics
    Inventors: Nazeer H. Shareef, James E. Smous, James P. Albarella
  • Publication number: 20040115832
    Abstract: A device for evaluating at least one analyte in a test sample. The device comprises a cassette having a hollow test chamber, a test strip disposed within the test chamber for receiving the test sample, and a temperature control member. The cassette has at least one aperture extending from an exterior of the cassette to the hollow test chamber. The test strip includes a reagent adapted to react with the at least one analyte to produce a reaction indicative of the presence of the analyte. The temperature control member is adapted to extend through the at least one aperture in the cassette and into the test chamber for controlling the temperature of the test chamber.
    Type: Application
    Filed: October 22, 2003
    Publication date: June 17, 2004
    Inventors: Nazeer H. Shareef, James E. Smous, James P. Albarella
  • Publication number: 20040092804
    Abstract: A system for determining the concentration of an analyte in at least one body fluid in body tissue, the system comprising an infrared light source, a body tissue interface, a detector, and a central processing unit. The body tissue interface is adapted to contact body tissue and to deliver light from the infrared light source to the contacted body tissue. The detector is adapted to receive spectral information corresponding to infrared light transmitted through the portion of body tissue being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid, the algorithm adapted to convert the received spectral information into the concentration of the analyte in at least one body fluid.
    Type: Application
    Filed: February 11, 2003
    Publication date: May 13, 2004
    Applicant: Bayer Healthcare, LLC
    Inventors: Mihailo V. Rebec, James E. Smous, Steven D. Brown, Hu-Wei Tan
  • Patent number: 5452390
    Abstract: A detachable fiber optic connector provides connection from an optical source or sink through a hermetic connection to a removable attached optical fiber. Ferrules and a split ring are used for alignment. A variety of alternative embodiments are illustrated for providing coupling force between the ferrules and retaining forces to prevent movement of the connection during movement of the fiber relative to the optical source or sink. These detachable fiber optic connectors provide great benefit when combined with hermetic packaging.
    Type: Grant
    Filed: April 22, 1994
    Date of Patent: September 19, 1995
    Assignee: CTS Corporation
    Inventors: J. Scott Bechtel, Steven B. Creswick, James E. Smous
  • Patent number: 5450515
    Abstract: A detachable fiber optic connector provides connection from an optical source or sink through a hermetic connection to a removable attached optical fiber. Ferrules and a split ring are used for alignment. A variety of alternative embodiments are illustrated for providing coupling force between the ferrules and retaining forces to prevent movement of the connection during movement of the fiber relative to the optical source or sink. These detachable fiber optic connectors provide great benefit when combined with hermetic packaging.
    Type: Grant
    Filed: April 22, 1994
    Date of Patent: September 12, 1995
    Assignee: CTS Corporation
    Inventors: J. Scott Bechtel, Steven B. Creswick, James E. Smous
  • Patent number: 5434941
    Abstract: A detachable fiber optic connector provides connection from an optical source or sink through a hermetic connection to a removable attached optical fiber. Ferrules and a split ring are used for alignment. A variety of alternative embodiments are illustrated for providing coupling force between the ferrules and retaining forces to prevent movement of the connection during movement of the fiber relative to the optical source or sink. These detachable fiber optic connectors provide great benefit when combined with hermetic packaging.
    Type: Grant
    Filed: April 22, 1994
    Date of Patent: July 18, 1995
    Assignee: CTS Corporation
    Inventors: J. Scott Bechtel, Steven B. Creswick, James E. Smous
  • Patent number: 5432878
    Abstract: An optoelectronic subassembly is illustrated which ensures the alignment of multiple optoelectronic devices without special assembly process. The optoelectronic devices are mounted upon specially designed sub-carriers which may be used to test the devices prior to completing the subassembly. The subassembly improves yields of complex optoelectronic systems and lowers resultant production costs.
    Type: Grant
    Filed: March 3, 1994
    Date of Patent: July 11, 1995
    Assignee: CTS Corporation
    Inventor: James E. Smous
  • Patent number: 5281819
    Abstract: Apparatus and an associated method for nondestructively determining the thickness of a coating on a metal surface, such as the interior of a can. An object securing device holds the object being inspected. The inspection device includes a probe. Positioning apparatus is employed to permit insertion of the probe into inspecting relationship which in the case of a can would involve partial insertion of the probe into the can. A first section is inspected and sequentially through relative rotational and/or translational movement of the object being inspected additional portions of the object such as can ends may be inspected. A light beam is caused to impinge upon the section of the object being inspected and returned fluorescent light received by a detector positioned within the probe cooperates with processing means to determine the coating thickness. The system permits accurate determinations of coating thickness even when the metal surface has irregularities.
    Type: Grant
    Filed: June 6, 1991
    Date of Patent: January 25, 1994
    Assignee: Aluminum Company of America
    Inventors: Richard G. Keffert, M. Jonell Kerkhoff, James E. Smous, Richard G. Keffert